| Literature DB >> 32616264 |
Lumin Yu1, Wenchang Li1, Qian Li1, Xiaolin Chen1, Jingtian Ni1, Fei Shang2, Ting Xue3.
Abstract
Avian pathogenic Escherichia coli (APEC) is a specific group of extraintestinal pathogenic E. coli that causes a variety of extraintestinal diseases in chickens, ducks, pigeons, turkeys, and other avian species. These diseases lead to significant economic losses in the poultry industry worldwide. However, owing to excessive use of antibiotics in the treatment of infectious diseases, bacteria have developed antibiotic resistance. The development of multidrug efflux pumps is one important bacterial antibiotic resistance mechanism. A multidrug efflux pump, MdtH, which belongs to the major facilitator superfamily of transporters, confers resistance to quinolone antibiotics such as norfloxacin and enoxacin. LsrR regulates hundreds of genes that participate in myriad biological processes, including mobility, biofilm formation, and antibiotic susceptibility. However, whether LsrR regulates mdtH transcription and then affects bacterial resistance to various antibiotics in APEC has not been reported. In the present study, the lsrR mutant was constructed from its parent strain APECX40 (WT), and high-throughput sequencing was performed to analyze the transcriptional profile of the WT and mutant XY10 strains. The results showed that lsrR gene deletion upregulated the mdtH transcript level. Furthermore, we also constructed the lsrR- and mdtH-overexpressing strains and performed antimicrobial susceptibility testing, antibacterial activity assays, real-time reverse transcription PCR, and electrophoretic mobility shift assays to investigate the molecular regulatory mechanism of LsrR on the MdtH multidrug efflux pump. The lsrR mutation and the mdtH-overexpressing strain decreased cell susceptibility to norfloxacin, ofloxacin, ciprofloxacin, and tetracycline by upregulating mdtH transcript levels. In addition, the lsrR-overexpressing strain increased cell susceptibility to norfloxacin, ofloxacin, ciprofloxacin, and tetracycline by downregulating mdtH transcript levels. Electrophoretic mobility shift assays indicated that LsrR directly binds to the mdtH promoter. Therefore, this study is the first to demonstrate that LsrR inhibits mdtH transcription by directly binding to its promoter region. This action subsequently increases susceptibility to the aforementioned four antibiotics in APECX40.Entities:
Keywords: LsrR; MdtH; avian pathogenic Escherichia coli; multidrug efflux pump; the antibiotic susceptibility
Year: 2020 PMID: 32616264 PMCID: PMC7597812 DOI: 10.1016/j.psj.2020.03.064
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Strains and plasmids used in this study.
| Strain or plasmid | Relevant genotype | Reference or source |
|---|---|---|
| Strains | ||
| | ||
| DH5α | Clone host strain, | Invitrogen |
| BL21 | Expression strain, F- | Invitrogen |
| WT | Avian pathogenic | Laboratory stock |
| XY10 | APECX40 | This study |
| WT/pSTV28 | WT with the empty vector pSTV28, Cmr | This study |
| XY10/pSTV28 | XY10 with the empty vector pSTV28, Cmr | This study |
| XY10/pClsrR | XY10 with the complement plasmid pClsrR,Cmr | This study |
| WT/pUC19 | WT with the empty vector pUC19, Ampr | This study |
| WT/pUCmdtH | WT with the overexpression plasmid pUCmdtH, Ampr | This study |
| WT/pUClsrR | WT with the overexpression plasmid pUClsrR, Ampr | This study |
| Plasmids | ||
| pKD46 | Expresses λ Red recombinase Exo, Bet and Gam, temperature sensitive, Ampr | Reference 41 |
| pKD3 | Reference 41 | |
| pCP20 | Reference 41 | |
| pSTV28 | Low copy number cloning vector, Cmr | TaKaRa |
| pClsrR | pSTV28 with | This study |
| pUC19 | Cloning vector, Ampr | Takara |
| pUClsrR | pUC19 with | This study |
| pUCmdtH | pUC19 with | This study |
| pET28a(+) | Expression vector, Kanr | Novagen |
| pET-lsrR | pET28a(+) with | This study |
Abbreviations: Ampr, ampicillin-resistant; Cmr, chloramphenicol-resistant; Kanr, kanamycin-resistant.
Oligonucleotide primers used in this study.
| Primer name | Oligonucleotide (5′-3′) |
|---|---|
| lsrR-f | ATGACAATCAACGATTCG |
| lsrR-r | TTAACTACGTAAAATCGC |
| APECO2-lsrR-f | ATCGTCTCGGCCTGACCCGTTTGAAAGTGTCGCGATTACTTGTAGGCTGGAGCTGCTT |
| APECO2-lsrR-r | TAATATTCACGCTGCACTCCGCGTTAAGCTGCCCGATACCTGAATATCCTCCTTAGTTC |
| CHECK-lsrR-f | GCGCAAGAACTGAACAATTG |
| CHECK-lsrR-r | CTATTTGATTGCCTTCCAGG |
| CM-f | TGTAGGCTGGAGCTGCTT |
| CM-r | CATATGAATATCCTCCTTAGTTC |
| lsrR-EcoRI-f | CG |
| lsrR-KpnI-r | GG |
| lsrR-KpnI-f | GG |
| lsrR-EcoRI-r | CG |
| mdtH-KpnI-f | GG |
| mdtH-EcoRI-r | CG |
| lsrR-NcoI-f | CATG |
| lsrR-XhoI-r | CCG |
| M13-f | TGTAAAACGACGGCCAGT |
| M13-r | CAGGAAACAGCTATGACC |
| T7-f | TAATACGACTCACTATAGGG |
| T7-r | TGCTAGTTATTGCTCAGCGG |
| rt-16s-f | TTTGAGTTCCCGGCC |
| rt-16s-r | CGGCCGCAAGGTTAA |
| rt-mdtH-f | GCGAGGAACCTGGGTAAA |
| rt-mdtH-r | CCGCCGAAAATACCCAGA |
| p-yfgF-biotin-f | AGATGCTCAGCAGAATCC |
| p-yfgF-r | CATGATAAACGTAATAAT |
| p-mdtH-biotin-f | TTCCCCTCCCGGGAAATAAA |
| p-mdtH-r | TCTATACCTACTCCTTCCCG |
The sequences with the underline refer to the restriction endonuclease recognition sites.
Differentially expressed genes whose mRNA levels (log2FC) displayed >0.6-fold decreases in the lsrR-deficient mutant XY10 compared with the WT strain.
| Gene | Product | log2FC | |
|---|---|---|---|
| APECO2_RS03445 | Methylisocitrate lyase | −1.30 | |
| APECO2_RS16285 | Hydroxyglutarate oxidase | −1.25 | |
| APECO2_RS03310 | - | LuxR family transcriptional regulator | −1.57 |
| APECO2_RS03450 | 2-methylcitrate synthase | −1.03 | |
| APECO2_RS17500 | MULTISPECIES: xanthine permease XanQ | −1.60 | |
| APECO2_RS07530 | MULTISPECIES: flagellar L-ring protein | −2.25 | |
| APECO2_RS07010 | Hydrogenase 2 large subunit | −0.99 |
Differentially expressed genes whose mRNA levels (log2FC) displayed >0.6-fold increases in the lsrR-deficient mutant XY10 compared with the WT strain.
| Gene | Product | log2FC | |
|---|---|---|---|
| APECO2_RS10070 | Autoinducer 2 ABC transporter ATP-binding protein LsrA | 5.36 | |
| APECO2_RS10075 | Autoinducer 2 ABC transporter permease LsrC | 5.74 | |
| APECO2_RS10090 | 3-hydroxy-5-phosphonooxypentane-2,4-dione thiolase LsrF | 4.61 | |
| APECO2_RS10085 | MULTISPECIES: autoinducer 2 ABC transporter substrate-binding protein | 4.30 | |
| APECO2_RS10095 | MULTISPECIES: autoinducer 2-degrading protein LsrG | 4.50 | |
| APECO2_RS10080 | MULTISPECIES: autoinducer 2 import system permease LsrD | 4.97 | |
| APECO2_RS10060 | Autoinducer-2 kinase | 3.09 | |
| APECO2_RS10065 | Transcriptional regulator | 2.07 | |
| APECO2_RS09645 | MULTISPECIES: hypothetical protein | 1.10 | |
| APECO2_RS10525 | MULTISPECIES: hypothetical protein | 3.10 | |
| APECO2_RS17345 | MULTISPECIES: YgdI/YgdR family lipoprotein | 1.03 | |
| APECO2_RS08740 | - | hypothetical protein | 1.40 |
| APECO2_RS25980 | MULTISPECIES: hypothetical protein | 1.68 | |
| APECO2_RS25335 | Fumarate hydratase | 2.81 | |
| APECO2_RS26595 | - | Hypothetical protein | 1.65 |
| APECO2_RS17745 | PTS mannitol transporter subunit IIBC | 3.76 | |
| APECO2_RS07460 | MFS transporter,response to antibiotic | 1.14 | |
| APECO2_RS19525 | MULTISPECIES: tRNA-binding protein | 2.00 | |
| APECO2_RS06250 | MULTISPECIES: formate C-acetyltransferase/glycerol dehydratase family glycyl radical enzyme | 1.06 | |
| APECO2_RS15950 | MULTISPECIES: ferredoxin | 1.07 | |
| APECO2_RS25665 | - | MULTISPECIES: hypothetical protein | 1.01 |
| APECO2_RS19370 | - | DNA-binding protein | 1.13 |
| APECO2_RS11595 | MULTISPECIES: GlsB/YeaQ/YmgE family stress response membrane protein | 0.95 | |
| APECO2_RS03705 | MULTISPECIES: hypothetical protein | 0.93 | |
| APECO2_RS08305 | MULTISPECIES: GlsB/YeaQ/YmgE family stress response membrane protein | 0.95 | |
| APECO2_RS19155 | MULTISPECIES: glycogen synthase | 0.85 | |
| APECO2_RS16460 | MULTISPECIES: carbon storage regulator | 0.81 | |
| APECO2_RS20295 | MULTISPECIES: barnase inhibitor | 0.89 | |
| APECO2_RS04795 | MULTISPECIES: hypothetical protein | 0.75 | |
| APECO2_RS04755 | MULTISPECIES: cold-shock protein CspE | 0.72 | |
| APECO2_RS11830 | MULTISPECIES: hypothetical protein | 0.70 | |
| APECO2_RS12035 | MULTISPECIES: copper homeostasis protein CutC | 0.78 | |
| APECO2_RS09925 | MULTISPECIES: stationary-phase-induced ribosome-associated protein | 0.71 | |
| APECO2_RS08655 | MULTISPECIES: hypothetical protein | 0.70 | |
| APECO2_RS15075 | MULTISPECIES: hypothetical protein | 0.68 | |
| APECO2_RS07160 | MULTISPECIES: hypothetical protein | 0.70 | |
| APECO2_RS08735 | MULTISPECIES: hypothetical protein | 0.70 | |
| APECO2_RS11755 | MULTISPECIES: DUF2527 domain-containing protein | 0.69 | |
| APECO2_RS24175 | Sulfurtransferase TusB | 0.78 | |
| APECO2_RS06985 | MULTISPECIES: acylphosphatase | 0.75 | |
| APECO2_RS24945 | MULTISPECIES: CsbD family protein | 0.64 | |
| APECO2_RS24850 | Hypothetical protein | 0.78 | |
| APECO2_RS03940 | MULTISPECIES: protein BolA | 0.62 | |
| APECO2_RS11270 | MULTISPECIES: hypothetical protein | 0.61 | |
| APECO2_RS11775 | MULTISPECIES: hypothetical protein | 0.98 | |
| APECO2_RS02455 | MULTISPECIES: hypothetical protein | 0.75 | |
| APECO2_RS04770 | MULTISPECIES: twin-arginine translocase subunit TatA | 0.61 | |
| APECO2_RS00685 | MULTISPECIES: HxlR family transcriptional regulator | 0.87 | |
| APECO2_RS10875 | MULTISPECIES: DUF1289 domain-containing protein | 0.73 | |
| APECO2_RS06140 | MULTISPECIES: DksA/TraR family C4-type zinc finger protein | 0.61 | |
| APECO2_RS17580 | MULTISPECIES: antitoxin CptB | 0.64 | |
| APECO2_RS11915 | MULTISPECIES: phosphogluconate dehydratase | 0.67 |
Susceptibility of Escherichia coli strains to various antibiotics.
| Strains | MIC (μg/mL) | |||
|---|---|---|---|---|
| CIP | Nor | Of | TET | |
| WT/pSTV28 | 2 | 2 | 2 | 128 |
| XY10/pSTV28 | 2 | 2 | 2 | 256 |
| XY10/pClsrR | 2 | 2 | 2 | 128 |
| WT/pUC19 | 4 | 4 | 4 | 256 |
| WT/pUClsrR | 4 | 4 | 4 | 256 |
| WT/pUCmdtH | 4 | 4 | 4 | 256 |
Abbreviations: CIP, ciprofloxacin; MIC, minimal inhibitory concentration; NOR, norfloxacin; OF, ofloxacin; TET, tetracycline.
Figure 1CFU assays of the lsrR-deficient strain XY10/pSTV28, the complement strain XY10/pClsrR, and their parent strain WT/pSTV28 in the presence of 4 antibiotics. Data are shown for (A) ciprofloxacin, (B) norfloxacin, (C) ofloxacin, and (D) tetracycline. The survival rate of WT/pSTV28 was designated as 100%. The XY10/pSTV28 and XY10/pClsrR colony counts were compared with those of WT/pSTV28. Error bars indicate SD; ∗∗P < 0.01 and indicates a significant difference between WT/pSTV28, XY10/pSTV28, and/or XY10/pClsrR.
Figure 2CFU assays of the lsrR-overexpressed strain WT/pUClsrR, and its parent strain WT/pUC19 in the presence of 4 antibiotics. Data are shown for (A) ciprofloxacin, (B) norfloxacin, (C) ofloxacin, and (D) tetracycline. The survival rate of WT/pUC19 was designated as 100%. The WT/pUClsrR colony counts were compared with those of WT/pUC19. Error bars indicate SD; ∗∗P < 0.01 and indicates a significant difference between WT/pUC19 and WT/pUClsrR.
Figure 3CFU assays of the mdtH-overexpressing strain WT/pUCmdtH, and its parent strain WT/pUC19 in the presence of 4 antibiotics. Data are shown for (A) ciprofloxacin, (B) norfloxacin, (C) ofloxacin, and (D) tetracycline. The survival rate of WT/pUC19 was designated as 100%. The WT/pUCmdtH colony counts were compared with those of WT/pUC19. Error bars indicate SD; ∗∗P < 0.01 and indicates a significant difference between WT/pUC19 and WT/pUCmdtH.
Figure 4Comparative measurement of transcription (complementary DNA [cDNA] abundance) of the multidrug efflux pump–encoding gene mdtH in the lsrR-deficient strain, the lsrR- and mdtH-overexpressing strains, and their parent strain. (A) The relative mdtH transcript level was determined by RT-qPCR in WT/pSTV28, XY10/pSTV28, and XY10/pClsrR bacteria cultured in LB broth with 16 μg/mL chloramphenicol. (B) The relative mdtH transcript level was determined by RT-qPCR in WT/pUC19 and WT/pUClsrR bacteria cultured in LB broth with 100 μg/mL ampicillin (Amp). (C) The relative mdtH transcript level was determined by RT-qPCR in WT/pUC19 and WT/pUCmdtH bacteria cultured in LB broth with 100 μg/mL Amp. Error bars indicate SD; ∗∗P < 0.01 and indicates a significant difference between WT/pSTV28, XY10/pSTV28, and XY10/pClsrR or WT/pUC19, WT/pUClsrR, and WT/pUCmdtH. Abbreviations: LB, Luria–Bertani; RT-qPCR, reverse transcriptase PCR.
Figure 5The binding ability of LsrR to the mdtH promoter was determined by gel shift assays. Increasing LsrR amounts were incubated with biotin-labeled yfgF and mdtH promoters (biotin-p-yfgF and biotin-p-mdtH). In each panel, from lanes (1) to (6), the LsrR concentrations were 8, 0, 1, 2, 4, and 8 μmol, respectively; the amount of biotin-labeled probes in all lanes was 200 fmol. In lane 1, besides the labeled probes, 2 pmol unlabeled probe was added as the competitive control (Ctrl). (A) The positive control, which demonstrates the binding ability of LsrR to the yfgF promoter and (B) the mdtH promoter.